During the 1990s, the commonly used weight-loss drug combination of fenfluramine and phenteramine was, is some patients, associated with the development of thickedned plaques on the cardiac valves. These patients were prone to develop MR, as well as aortic regurgitaion and tricuspid valve disease. (PPC. 204)